The US Food and Drug Administration (FDA) has expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a g...
Ascend Advanced Therapies (Ascend), a total solutions gene therapy development partner, has acquired the CMC ...
Ideally, the antigen for a traditional CAR T-cell (or a T-cell) would be universally and homogeneously expressed on canc...
Cancer research has come a long way. Along with technology advancements, the basic options for treating cancer, such as ...
The most sought-after and hot sector in the pharmaceutical industry, which has witnessed an outpouring of billions and r...
Polyplus (part of Sartorius, a distinguished upstream solutions provider for biologic and cell and gene the...
The China Association for Science and Technology (CAS) Consortium of Life Sciences Societies is proud to announce the ...
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing...
The US Food and Drug Administration (FDA) has approved Amtagvi, the first cellular therapy indicated for the treatment o...
This innovative field relies on the delivery of specific genes into a patient's cells to treat or prevent disease, a pro...
Japan-based Astellas Pharma Inc. has entered into a strategic collaboration with US-based Mass General Brigham ...
US-based Vertex Pharmaceuticals Incorporated has announced that the Saudi Food and Drug Authority (SFDA) has g...
Tony Li, Senior Director and Head of Medical Affairs, Intercontinental Region, Gilead and Kite Oncology Kite Pharma, a ...
The teams will work to improve process efficiency leveraging Polyplus products and expertise with MarkHerz man...
Dr. Liu Wei Co-founder & CEO, CytoNiche, Shanghai, China China-based CytoNiche Biotechnology, a pioneer in 3D disso...
